Other Open Access

Statistical Data Analysis Plan HPV Quadrivalent HPV Vaccine CIN/Wart Efficacy Study (Study 013) - March 2003 / Statistical Data Analysis Plan HPV Quadrivalent HPV Vaccine, Safety, Immunogeneicity and Efficacy Study (Study 015) FUTURE II - July 2003

Lupinacci, Lisa; Railkhar, Radha

2003_FDA_r_s_DAP-Gardasil-HPV-013.pdf

Statistical Data Analysis Plan HPV Quadrivalent HPV Vaccine CIN/Wart Efficacy Study (Study 013) March 2003


2003_FDA_r_s_DAP-Gardasil-HPV-015.pdf

Statistical Data Analysis Plan HPV Quadrivalent HPV Vaccine, Safety, Immunogenicity and Efficacy Study (Study 015) FUTURE II - July 2003


We obtained Gardasil® Data Analysis Plans (DAPs) from the FDA through Freedom of Information Act (FOIA) request. The above linked DAPs specified a “per protocol analysis” for the outcome CIN 2+ irrespective of HPV type.

Files (6.2 MB)
Name Size
2003_FDA_r_s_DAP-Gardasil-HPV-013.pdf
md5:05c48505dce234778e2c5aa9f1e8b3e0
2.7 MB Download
2003_FDA_r_s_DAP-Gardasil-HPV-015.pdf
md5:c9500e80ede7382540f187fc65f24ad9
3.5 MB Download
232
108
views
downloads
All versions This version
Views 232232
Downloads 108108
Data volume 307.0 MB307.0 MB
Unique views 219219
Unique downloads 7575

Share

Cite as